Business · 30/10/2020Updated: 10/17/2026 · 1 min read
Sanofi-Aventis U.S. LLC, et al. Withdraw FDA Approval of 11 Abbreviated New Drug Applications
Summary
The US Food and Drug Administration (FDA) has withdrawn the approval of 11 abbreviated new drug applications (ANDAs) from multiple applicants, following written notifications that the drug products were no longer commercially available.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →